TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP702	Metapathway biotransformation	1.42046653896346e-19	-43.3981314006681	177	14	0.875	16	5310	266722,9953,9394,9653,64579,9957,9348,64711,8509,9956,9951,3340,9955,90161	HS6ST3,HS3ST3B1,HS6ST1,HS2ST1,NDST4,HS3ST1,NDST3,HS3ST6,NDST2,HS3ST2,HS3ST4,NDST1,HS3ST3A1,HS6ST2
WP2857	Mesodermal Commitment Pathway	0.0777630012956139	-2.55408952266618	155	2	0.125	16	5310	2132,2131	EXT2,EXT1
WP2853	Endoderm Differentiation	0.358292963354072	-1.02640429384239	145	1	0.0625	16	5310	2131	EXT1
WP3594	Circadian rythm related genes	0.471192212579651	-0.752489173564751	207	1	0.0625	16	5310	9956	HS3ST2
WP176	Folate Metabolism	0.999999999996866	-3.13357452042892e-12	69	0	0	16	5310
WP2369	Histone Modifications	0.999999999996866	-3.13357452042892e-12	69	0	0	16	5310
WP707	DNA Damage Response	0.999999999996866	-3.13357452042892e-12	69	0	0	16	5310
WP2447	Amyotrophic lateral sclerosis (ALS)	0.999999999996879	-3.12141605309085e-12	38	0	0	16	5310
WP2029	Cell Differentiation - Index	0.999999999996879	-3.12141605309085e-12	38	0	0	16	5310
WP2526	PDGF Pathway	0.999999999996879	-3.12141605309085e-12	38	0	0	16	5310
WP383	Striated Muscle Contraction	0.999999999996879	-3.12141605309085e-12	38	0	0	16	5310
WP3297	EV release from cardiac cells and their functional effects	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP3585	Cytosine methylation	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP3875	ATR Signaling	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP561	Heme Biosynthesis	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP3300	Dual hijack model of Vif in HIV infection	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP696	Benzo(a)pyrene metabolism	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP3674	Tgif disruption of Shh signaling	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP288	NLR Proteins	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP531	Mismatch repair	0.999999999998973	-1.02740774861603e-12	9	0	0	16	5310
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.999999999999705	-2.95205731510919e-13	70	0	0	16	5310
WP428	Wnt Signaling Pathway	0.999999999999705	-2.95205731510919e-13	70	0	0	16	5310
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	1.00000000000056	5.6044649327702e-13	27	0	0	16	5310
WP3845	Canonical  and Non-canonical Notch signaling	1.00000000000056	5.6044649327702e-13	27	0	0	16	5310
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP3871	Valproic acid pathway	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP1434	Osteopontin Signaling	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP3892	Development of pulmonary dendritic cells and macrophage subsets	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP2881	Estrogen Receptor Pathway	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP186	Homologous recombination	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP1423	Ganglio Sphingolipid Metabolism	1.00000000000103	1.0325717338545e-12	13	0	0	16	5310
WP2267	Synaptic Vesicle Pathway	1.0000000000013	1.29840033251473e-12	52	0	0	16	5310
WP43	Oxidation by Cytochrome P450	1.00000000000166	1.65868479453891e-12	63	0	0	16	5310
WP3624	Lung fibrosis	1.00000000000166	1.65868479453891e-12	63	0	0	16	5310
WP2879	Farnesoid X Receptor  Pathway	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP697	Estrogen metabolism	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP1992	TarBasePathway	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP404	Nucleotide Metabolism	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP384	Apoptosis Modulation by HSP70	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP3287	Overview of nanoparticle effects	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP247	Small Ligand GPCRs	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP22	IL-9 Signaling Pathway	1.00000000000198	1.98143363462462e-12	19	0	0	16	5310
WP334	GPCRs, Class B Secretin-like	1.00000000000199	1.99031859670046e-12	24	0	0	16	5310
WP1539	Angiogenesis	1.00000000000199	1.99031859670046e-12	24	0	0	16	5310
WP262	EBV LMP1 signaling	1.00000000000199	1.99031859670046e-12	24	0	0	16	5310
WP2509	Nanoparticle triggered autophagic cell death	1.00000000000199	1.99031859670046e-12	24	0	0	16	5310
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	1.00000000000199	1.99031859670046e-12	24	0	0	16	5310
WP195	IL-1 signaling pathway	1.00000000000261	2.60657701807437e-12	57	0	0	16	5310
WP2795	Cardiac Hypertrophic Response	1.00000000000261	2.60657701807437e-12	57	0	0	16	5310
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	1.00000000000261	2.60814288284146e-12	5	0	0	16	5310
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	1.00000000000261	2.60814288284146e-12	5	0	0	16	5310
WP311	Synthesis and Degradation of Ketone Bodies	1.00000000000261	2.60814288284146e-12	5	0	0	16	5310
WP3596	miR-517 relationship with ARCN1 and USP1	1.00000000000261	2.60814288284146e-12	5	0	0	16	5310
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	1.00000000000261	2.60814288284146e-12	5	0	0	16	5310
WP2542	Sulindac Metabolic Pathway	1.00000000000261	2.60814288284146e-12	5	0	0	16	5310
WP477	Cytoplasmic Ribosomal Proteins	1.0000000000029	2.90458700040279e-12	90	0	0	16	5310
WP138	Androgen receptor signaling pathway	1.0000000000029	2.90458700040279e-12	90	0	0	16	5310
WP179	Cell Cycle	1.00000000000326	3.25816972718616e-12	105	0	0	16	5310
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	1.00000000000361	3.60986812067516e-12	44	0	0	16	5310
WP716	Vitamin A and Carotenoid Metabolism	1.00000000000361	3.60986812067516e-12	44	0	0	16	5310
WP2332	Interleukin-11 Signaling Pathway	1.00000000000361	3.60986812067516e-12	44	0	0	16	5310
WP2012	miRs in Muscle Cell Differentiation	1.00000000000409	4.09381769699659e-12	36	0	0	16	5310
WP3298	Melatonin metabolism and effects	1.00000000000409	4.09381769699659e-12	36	0	0	16	5310
WP500	Glycogen Metabolism	1.00000000000409	4.09381769699659e-12	36	0	0	16	5310
WP2485	NAD Biosynthesis II (from tryptophan)	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP2276	Glial Cell Differentiation	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP136	Phase I biotransformations, non P450	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP1589	Folate-Alcohol and Cancer Pathway	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP1604	Codeine and Morphine Metabolism	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP3407	FTO Obesity Variant Mechanism	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP2338	miRNA Biogenesis	1.00000000000415	4.15080564682673e-12	8	0	0	16	5310
WP2059	Alzheimers Disease	1.00000000000453	4.53110172572485e-12	148	0	0	16	5310
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	1.00000000000457	4.57365498625108e-12	47	0	0	16	5310
WP1971	Integrated Cancer Pathway	1.00000000000476	4.75716647802442e-12	46	0	0	16	5310
WP268	Notch Signaling Pathway	1.00000000000476	4.75716647802442e-12	46	0	0	16	5310
WP465	Tryptophan metabolism	1.00000000000476	4.75716647802442e-12	46	0	0	16	5310
WP3878	ATM Signaling Network in Development and Disease	1.00000000000476	4.75716647802442e-12	46	0	0	16	5310
WP28	Selenium Metabolism and Selenoproteins	1.00000000000476	4.75716647802442e-12	46	0	0	16	5310
WP1591	Heart Development	1.00000000000476	4.75716647802442e-12	46	0	0	16	5310
WP2261	Signaling Pathways in Glioblastoma	1.00000000000481	4.80717947057105e-12	83	0	0	16	5310
WP2371	Parkinsons Disease Pathway	1.00000000000481	4.80717947057105e-12	83	0	0	16	5310
WP254	Apoptosis	1.00000000000481	4.81434997619935e-12	86	0	0	16	5310
WP481	Insulin Signaling	1.00000000000529	5.29004934637555e-12	161	0	0	16	5310
WP2637	Structural Pathway of Interleukin 1 (IL-1)	1.00000000000556	5.55997276751013e-12	50	0	0	16	5310
WP1545	miRNAs involved in DNA damage response	1.00000000000556	5.55997276751013e-12	50	0	0	16	5310
WP3865	RIG-I-like Receptor Signaling	1.00000000000579	5.7924159861485e-12	61	0	0	16	5310
WP325	Triacylglyceride Synthesis	1.00000000000582	5.82264590563495e-12	26	0	0	16	5310
WP698	Glucuronidation	1.00000000000582	5.82264590563495e-12	26	0	0	16	5310
WP530	Cytokines and Inflammatory Response	1.00000000000582	5.82264590563495e-12	26	0	0	16	5310
WP26	Signal Transduction of S1P Receptor	1.00000000000582	5.82264590563495e-12	26	0	0	16	5310
WP2878	PPAR Alpha Pathway	1.00000000000582	5.82264590563495e-12	26	0	0	16	5310
WP581	EPO Receptor Signaling	1.00000000000582	5.82264590563495e-12	26	0	0	16	5310
WP1530	miRNA Regulation of DNA Damage Response	1.00000000000593	5.92908555227753e-12	93	0	0	16	5310
WP2355	Corticotropin-releasing hormone signaling pathway	1.00000000000593	5.92908555227753e-12	93	0	0	16	5310
WP691	Tamoxifen metabolism	1.00000000000609	6.08652785110146e-12	21	0	0	16	5310
WP1602	Nicotine Activity on Dopaminergic Neurons	1.00000000000609	6.08652785110146e-12	21	0	0	16	5310
WP2533	Glycerophospholipid Biosynthetic Pathway	1.00000000000609	6.08652785110146e-12	21	0	0	16	5310
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	1.00000000000609	6.08652785110146e-12	21	0	0	16	5310
WP2507	Nanomaterial induced apoptosis	1.00000000000609	6.08652785110146e-12	21	0	0	16	5310
WP382	MAPK Signaling Pathway	1.00000000000631	6.30787498945733e-12	170	0	0	16	5310
WP560	TGF-beta Receptor Signaling	1.00000000000631	6.31021643124271e-12	58	0	0	16	5310
WP35	G Protein Signaling Pathways	1.00000000000695	6.94925890744166e-12	95	0	0	16	5310
WP117	GPCRs, Other	1.00000000000695	6.94925890744166e-12	95	0	0	16	5310
WP558	Complement and Coagulation Cascades	1.00000000000702	7.02341581748586e-12	60	0	0	16	5310
WP3527	Preimplantation Embryo	1.00000000000702	7.02341581748586e-12	60	0	0	16	5310
WP304	Kit receptor signaling pathway	1.00000000000702	7.02341581748586e-12	60	0	0	16	5310
WP554	ACE Inhibitor Pathway	1.00000000000774	7.74393623050886e-12	17	0	0	16	5310
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	1.00000000000774	7.74393623050886e-12	17	0	0	16	5310
WP3874	Canonical and Non-Canonical TGF-B signaling	1.00000000000774	7.74393623050886e-12	17	0	0	16	5310
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	1.00000000000774	7.74393623050886e-12	17	0	0	16	5310
WP78	TCA Cycle	1.00000000000774	7.74393623050886e-12	17	0	0	16	5310
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	1.00000000000774	7.74393623050886e-12	17	0	0	16	5310
WP2289	Drug Induction of Bile Acid Pathway	1.00000000000774	7.74393623050886e-12	17	0	0	16	5310
WP2858	Ectoderm Differentiation	1.00000000000799	7.99101779270389e-12	143	0	0	16	5310
WP2884	NRF2 pathway	1.00000000000799	7.99101779270389e-12	143	0	0	16	5310
WP430	Statin Pathway	1.00000000000801	8.01011956031319e-12	33	0	0	16	5310
WP2363	Gastric Cancer Network 2	1.00000000000801	8.01011956031319e-12	33	0	0	16	5310
WP2197	Endothelin Pathways	1.00000000000801	8.01011956031319e-12	33	0	0	16	5310
WP58	Monoamine GPCRs	1.00000000000801	8.01011956031319e-12	33	0	0	16	5310
WP453	Inflammatory Response Pathway	1.00000000000801	8.01011956031319e-12	33	0	0	16	5310
WP3676	BDNF-TrkB Signaling	1.00000000000801	8.01011956031319e-12	33	0	0	16	5310
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	1.00000000000803	8.03004255052254e-12	35	0	0	16	5310
WP244	Alpha 6 Beta 4 signaling pathway	1.00000000000803	8.03004255052254e-12	35	0	0	16	5310
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.00000000000803	8.03004255052254e-12	35	0	0	16	5310
WP710	DNA Damage Response (only ATM dependent)	1.00000000000825	8.24739385411141e-12	114	0	0	16	5310
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	1.00000000000829	8.29491448736223e-12	42	0	0	16	5310
WP466	DNA Replication	1.00000000000829	8.29491448736223e-12	42	0	0	16	5310
WP405	Eukaryotic Transcription Initiation	1.00000000000829	8.29491448736223e-12	42	0	0	16	5310
WP2636	Common Pathways Underlying Drug Addiction	1.00000000000829	8.29491448736223e-12	42	0	0	16	5310
WP49	IL-2 Signaling Pathway	1.00000000000829	8.29491448736223e-12	42	0	0	16	5310
WP3925	Amino Acid metabolism	1.00000000000844	8.44092327841615e-12	91	0	0	16	5310
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	1.00000000000844	8.44092327841615e-12	91	0	0	16	5310
WP2377	Integrated Pancreatic Cancer Pathway	1.00000000000849	8.4908391248018e-12	197	0	0	16	5310
WP2805	RNA interference	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP1272	Selenium Micronutrient Network	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP3924	Hfe effect on hepcidin production	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP438	Non-homologous end joining	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP699	Aflatoxin B1 metabolism	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP1310	Selenium Micronutrient Network	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP1995	Effects of Nitric Oxide	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP2596	Gastric acid production	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP3595	mir-124 predicted interactions with cell cycle and differentiation	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP528	Acetylcholine Synthesis	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP134	Pentose Phosphate Pathway	1.00000000000856	8.55678578350237e-12	7	0	0	16	5310
WP1311	Folic Acid Network	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP1438	Influenza A virus infection	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP2866	mir34a and TGIF2 in osteoclastogenesis	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP2646	Lidocaine metabolism	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP2816	Felbamate Metabolism	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP2366	Butyrate-induced histone acetylation	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP2943	Hypoxia-mediated EMT and Stemness	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP1273	Folic Acid Network	1.00000000000867	8.6707638715744e-12	2	0	0	16	5310
WP2249	Metastatic brain tumor	1.00000000000872	8.72218848646375e-12	28	0	0	16	5310
WP2361	Gastric Cancer Network 1	1.00000000000872	8.72218848646375e-12	28	0	0	16	5310
WP1772	Apoptosis Modulation and Signaling	1.00000000000873	8.73340047531451e-12	94	0	0	16	5310
WP231	TNF alpha Signaling Pathway	1.00000000000873	8.73340047531451e-12	94	0	0	16	5310
WP2190	One carbon donor	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP1	Statin Pathway	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP3191	TSLP Signaling Pathway	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP2536	Colchicine Metabolic Pathway	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP661	Glucose Homeostasis	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP188	Focal Adhesion	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP3627	Gut-Liver Indole Metabolism	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP108	Selenium metabolism/Selenoproteins	1.00000000000874	8.73542384260961e-12	1	0	0	16	5310
WP2848	Differentiation Pathway	1.00000000000882	8.82038041976239e-12	48	0	0	16	5310
WP2873	Aryl Hydrocarbon Receptor Pathway	1.00000000000882	8.82038041976239e-12	48	0	0	16	5310
WP2586	Aryl Hydrocarbon Receptor	1.00000000000882	8.82038041976239e-12	48	0	0	16	5310
WP2849	Hematopoietic Stem Cell Differentiation	1.00000000000882	8.82038041976239e-12	48	0	0	16	5310
WP2328	Allograft Rejection	1.00000000000887	8.87229772035692e-12	80	0	0	16	5310
WP2911	miRNA targets in ECM and membrane receptors	1.00000000000892	8.92087356429325e-12	43	0	0	16	5310
WP364	IL-6 signaling pathway	1.00000000000892	8.92087356429325e-12	43	0	0	16	5310
WP2855	Dopaminergic Neurogenesis	1.00000000000895	8.9487778935911e-12	30	0	0	16	5310
WP241	One Carbon Metabolism	1.00000000000895	8.9487778935911e-12	30	0	0	16	5310
WP3851	TLR4 Signaling and Tolerance	1.00000000000895	8.9487778935911e-12	30	0	0	16	5310
WP2870	Extracellular vesicle-mediated signaling in recipient cells	1.00000000000895	8.9487778935911e-12	30	0	0	16	5310
WP129	Matrix Metalloproteinases	1.00000000000895	8.9487778935911e-12	30	0	0	16	5310
WP98	Prostaglandin Synthesis and Regulation	1.00000000000895	8.9487778935911e-12	30	0	0	16	5310
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1.00000000000895	8.9487778935911e-12	30	0	0	16	5310
WP183	Proteasome Degradation	1.0000000000092	9.20241308453934e-12	66	0	0	16	5310
WP2374	Oncostatin M Signaling Pathway	1.0000000000092	9.20241308453934e-12	66	0	0	16	5310
WP2324	AGE/RAGE pathway	1.0000000000092	9.20241308453934e-12	66	0	0	16	5310
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	1.0000000000092	9.20241308453934e-12	66	0	0	16	5310
WP712	Estrogen signaling pathway	1.00000000000925	9.2531303212885e-12	23	0	0	16	5310
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	1.00000000000925	9.2531303212885e-12	23	0	0	16	5310
WP2643	Nanoparticle-mediated activation of receptor signaling	1.00000000000926	9.25948211016574e-12	29	0	0	16	5310
WP2583	T-Cell Receptor and Co-stimulatory Signaling	1.00000000000926	9.25948211016574e-12	29	0	0	16	5310
WP3613	Photodynamic therapy-induced unfolded protein response	1.00000000000926	9.25948211016574e-12	29	0	0	16	5310
WP422	MAPK Cascade	1.00000000000926	9.25948211016574e-12	29	0	0	16	5310
WP1544	MicroRNAs in cardiomyocyte hypertrophy	1.00000000000926	9.26307948951066e-12	102	0	0	16	5310
WP2064	Neural Crest Differentiation	1.00000000000926	9.26307948951066e-12	102	0	0	16	5310
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	1.00000000000958	9.57943082460851e-12	144	0	0	16	5310
WP2516	ATM Signaling Pathway	1.00000000000959	9.5857332729702e-12	40	0	0	16	5310
WP524	G13 Signaling Pathway	1.00000000000959	9.5857332729702e-12	40	0	0	16	5310
WP127	IL-5 Signaling Pathway	1.00000000000959	9.5857332729702e-12	40	0	0	16	5310
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	1.00000000000962	9.62493416881637e-12	68	0	0	16	5310
WP45	G1 to S cell cycle control	1.00000000000962	9.62493416881637e-12	68	0	0	16	5310
WP3303	Rac1/Pak1/p38/MMP-2 pathway	1.00000000000962	9.62493416881637e-12	68	0	0	16	5310
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	1.00000000000962	9.62493416881637e-12	68	0	0	16	5310
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	1.00000000000962	9.62493416881637e-12	68	0	0	16	5310
WP1449	Regulation of toll-like receptor signaling pathway	1.00000000000974	9.73587112004827e-12	145	0	0	16	5310
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	1.00000000000985	9.84716913852528e-12	73	0	0	16	5310
WP3584	MECP2 and Associated Rett Syndrome	1.00000000000994	9.93565451791881e-12	62	0	0	16	5310
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	1.00000000000994	9.93565451791881e-12	62	0	0	16	5310
WP61	Notch Signaling Pathway	1.00000000000994	9.93565451791881e-12	62	0	0	16	5310
WP236	Adipogenesis	1.00000000001018	1.01817183786004e-11	131	0	0	16	5310
WP455	GPCRs, Class A Rhodopsin-like	1.0000000000102	1.0203188406352e-11	259	0	0	16	5310
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	1.00000000001033	1.03292897746122e-11	55	0	0	16	5310
WP395	IL-4 Signaling Pathway	1.00000000001033	1.03292897746122e-11	55	0	0	16	5310
WP2272	Pathogenic Escherichia coli infection	1.00000000001033	1.03292897746122e-11	55	0	0	16	5310
WP585	Interferon type I signaling pathways	1.00000000001033	1.03292897746122e-11	55	0	0	16	5310
WP2034	Leptin signaling pathway	1.00000000001067	1.06706723579186e-11	76	0	0	16	5310
WP2037	Prolactin Signaling Pathway	1.00000000001067	1.06706723579186e-11	76	0	0	16	5310
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	1.00000000001067	1.06706723579186e-11	76	0	0	16	5310
WP322	Osteoblast Signaling	1.00000000001081	1.08122065015802e-11	14	0	0	16	5310
WP2436	Dopamine metabolism	1.00000000001081	1.08122065015802e-11	14	0	0	16	5310
WP229	Irinotecan Pathway	1.00000000001081	1.08122065015802e-11	14	0	0	16	5310
WP3853	ERK Pathway in Huntington's Disease	1.00000000001081	1.08122065015802e-11	14	0	0	16	5310
WP3601	Composition of Lipid Particles	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP704	Methylation Pathways	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP2874	Liver X Receptor Pathway	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP2333	Trans-sulfuration pathway	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP496	Steroid Biosynthesis	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP1531	Vitamin D Metabolism	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP2113	Type III interferon signaling	1.00000000001083	1.08316265135808e-11	10	0	0	16	5310
WP1601	Fluoropyrimidine Activity	1.00000000001086	1.0859580749952e-11	34	0	0	16	5310
WP313	Signaling of Hepatocyte Growth Factor Receptor	1.00000000001086	1.0859580749952e-11	34	0	0	16	5310
WP400	p38 MAPK Signaling Pathway	1.00000000001086	1.0859580749952e-11	34	0	0	16	5310
WP143	Fatty Acid Beta Oxidation	1.00000000001086	1.0859580749952e-11	34	0	0	16	5310
WP2895	Differentiation of white and brown adipocyte	1.00000000001087	1.08718284922666e-11	25	0	0	16	5310
WP205	IL-7 Signaling Pathway	1.00000000001087	1.08718284922666e-11	25	0	0	16	5310
WP2865	IL1 and megakaryocytes in obesity	1.00000000001087	1.08718284922666e-11	25	0	0	16	5310
WP1528	Physiological and Pathological Hypertrophy  of the Heart	1.00000000001087	1.08718284922666e-11	25	0	0	16	5310
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	1.00000000001087	1.08718284922666e-11	25	0	0	16	5310
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	1.00000000001108	1.10760793315775e-11	3	0	0	16	5310
WP3408	Evolocumab Mechanism	1.00000000001108	1.10760793315775e-11	3	0	0	16	5310
WP3858	Toll-like Receptor Signaling	1.00000000001117	1.11658773687655e-11	32	0	0	16	5310
WP3893	Development and heterogeneity of the ILC family	1.00000000001117	1.11658773687655e-11	32	0	0	16	5310
WP34	Ovarian Infertility Genes	1.00000000001117	1.11658773687655e-11	32	0	0	16	5310
WP2875	Constitutive Androstane Receptor Pathway	1.00000000001117	1.11658773687655e-11	32	0	0	16	5310
WP2525	Trans-sulfuration and one carbon metabolism	1.00000000001117	1.11658773687655e-11	32	0	0	16	5310
WP2828	Bladder Cancer	1.00000000001117	1.11658773687655e-11	32	0	0	16	5310
WP727	Monoamine Transport	1.00000000001117	1.11658773687655e-11	32	0	0	16	5310
WP1422	Sphingolipid Metabolism	1.00000000001126	1.12622436341506e-11	20	0	0	16	5310
WP497	Urea cycle and metabolism of amino groups	1.00000000001126	1.12622436341506e-11	20	0	0	16	5310
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	1.00000000001126	1.12622436341506e-11	20	0	0	16	5310
WP1742	TP53 Network	1.00000000001126	1.12622436341506e-11	20	0	0	16	5310
WP516	Hypertrophy Model	1.00000000001126	1.12622436341506e-11	20	0	0	16	5310
WP391	Mitochondrial Gene Expression	1.00000000001126	1.12622436341506e-11	20	0	0	16	5310
WP306	Focal Adhesion	1.0000000000117	1.16977829736837e-11	195	0	0	16	5310
WP75	Toll-like Receptor Signaling Pathway	1.00000000001175	1.17468049247041e-11	103	0	0	16	5310
WP185	Integrin-mediated Cell Adhesion	1.00000000001175	1.17468049247041e-11	103	0	0	16	5310
WP534	Glycolysis and Gluconeogenesis	1.00000000001186	1.18579056304969e-11	49	0	0	16	5310
WP286	IL-3 Signaling Pathway	1.00000000001186	1.18579056304969e-11	49	0	0	16	5310
WP410	Diurnally Regulated Genes with Circadian Orthologs	1.00000000001186	1.18579056304969e-11	49	0	0	16	5310
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	1.00000000001207	1.20741512368973e-11	18	0	0	16	5310
WP3413	NOTCH1 regulation of human endothelial cell calcification	1.00000000001207	1.20741512368973e-11	18	0	0	16	5310
WP692	Sulfation Biotransformation Reaction	1.00000000001207	1.20741512368973e-11	18	0	0	16	5310
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	1.00000000001207	1.20741512368973e-11	18	0	0	16	5310
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	1.00000000001207	1.20741512368973e-11	18	0	0	16	5310
WP111	Electron Transport Chain	1.00000000001223	1.22293101552208e-11	92	0	0	16	5310
WP47	Hedgehog Signaling Pathway	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP1946	Cori Cycle	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP12	Osteoclast Signaling	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP53	ID signaling pathway	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP3644	NAD+ metabolism	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP550	Biogenic Amine Synthesis	1.00000000001228	1.22820931432559e-11	16	0	0	16	5310
WP437	EGF/EGFR Signaling Pathway	1.00000000001237	1.23681502638812e-11	162	0	0	16	5310
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	1.00000000001237	1.23681502638812e-11	162	0	0	16	5310
WP2889	Oxytocin signaling	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP1133	Androgen receptor signaling pathway	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP3633	Caffeine and Theobromine metabolism	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP2491	Diclofenac Metabolic Pathway	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP2253	Pilocytic astrocytoma	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP521	Amino acid conjugation of benzoic acid	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP733	Serotonin Receptor 2 and STAT3 Signaling	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP690	Polyol Pathway	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP1603	Nicotine Activity on Chromaffin Cells	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP897	Androgen receptor signaling pathway	1.00000000001254	1.25371121899495e-11	4	0	0	16	5310
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	1.00000000001292	1.29235621930154e-11	51	0	0	16	5310
WP3646	Hepatitis C and Hepatocellular Carcinoma	1.00000000001292	1.29235621930154e-11	51	0	0	16	5310
WP1533	Vitamin B12 Metabolism	1.00000000001293	1.29309442687548e-11	53	0	0	16	5310
WP107	Translation Factors	1.00000000001293	1.29309442687548e-11	53	0	0	16	5310
WP363	Wnt Signaling Pathway Netpath	1.00000000001293	1.29309442687548e-11	53	0	0	16	5310
WP2406	Cardiac Progenitor Differentiation	1.00000000001293	1.29309442687548e-11	53	0	0	16	5310
WP197	Cholesterol Biosynthesis	1.00000000001298	1.297859106018e-11	15	0	0	16	5310
WP206	Fatty Acid Omega Oxidation	1.00000000001298	1.297859106018e-11	15	0	0	16	5310
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000001298	1.297859106018e-11	15	0	0	16	5310
WP3	Transcriptional activation by NRF2	1.00000000001298	1.297859106018e-11	15	0	0	16	5310
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1.00000000001358	1.35822809172286e-11	31	0	0	16	5310
WP408	Oxidative Stress	1.00000000001358	1.35822809172286e-11	31	0	0	16	5310
WP2112	IL17 signaling pathway	1.00000000001358	1.35822809172286e-11	31	0	0	16	5310
WP694	Arylamine metabolism	1.00000000001419	1.41895031020972e-11	6	0	0	16	5310
WP1981	Thyroxine (Thyroid Hormone) Production	1.00000000001419	1.41895031020972e-11	6	0	0	16	5310
WP1600	Nicotine Metabolism	1.00000000001419	1.41895031020972e-11	6	0	0	16	5310
WP3891	Benzene metabolism	1.00000000001419	1.41895031020972e-11	6	0	0	16	5310
WP51	Regulation of Actin Cytoskeleton	1.00000000001454	1.4538081049614e-11	149	0	0	16	5310
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	1.00000000001476	1.47631031187434e-11	74	0	0	16	5310
WP24	Peptide GPCRs	1.00000000001476	1.47631031187434e-11	74	0	0	16	5310
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP106	Alanine and aspartate metabolism	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP2290	RalA downstream regulated genes	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP2007	Iron metabolism in placenta	1.00000000001477	1.4770704932818e-11	12	0	0	16	5310
WP170	Nuclear Receptors	1.00000000001498	1.49841699275609e-11	39	0	0	16	5310
WP366	TGF-beta Signaling Pathway	1.00000000001516	1.51634891295333e-11	133	0	0	16	5310
WP399	Wnt Signaling Pathway and Pluripotency	1.0000000000152	1.52023262667281e-11	106	0	0	16	5310
WP615	Senescence and Autophagy in Cancer	1.0000000000152	1.52023262667281e-11	106	0	0	16	5310
WP2431	Spinal Cord Injury	1.00000000001522	1.5224371658602e-11	119	0	0	16	5310
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	1.00000000001523	1.52327549082421e-11	41	0	0	16	5310
WP289	Myometrial Relaxation and Contraction Pathways	1.00000000001559	1.55930863598085e-11	158	0	0	16	5310
WP474	Endochondral Ossification	1.00000000001565	1.56451985513464e-11	65	0	0	16	5310
WP15	Selenium Micronutrient Network	1.00000000001579	1.57868257248816e-11	87	0	0	16	5310
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	1.00000000001579	1.57873970804936e-11	132	0	0	16	5310
WP411	mRNA Processing	1.00000000001579	1.57873970804936e-11	132	0	0	16	5310
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP3599	Transcription factor regulation in adipogenesis	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP167	Eicosanoid Synthesis	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP3645	NAD+ biosynthetic pathways	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP357	Fatty Acid Biosynthesis	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP545	Complement Activation	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP1584	Type II diabetes mellitus	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP100	Glutathione metabolism	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP272	Blood Clotting Cascade	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP1424	Globo Sphingolipid Metabolism	1.00000000001582	1.58165303818306e-11	22	0	0	16	5310
WP23	B Cell Receptor Signaling Pathway	1.00000000001602	1.6023756363183e-11	98	0	0	16	5310
WP1984	Integrated Breast Cancer Pathway	1.00000000001663	1.66276619747423e-11	154	0	0	16	5310
WP2446	Retinoblastoma (RB) in Cancer	1.00000000001708	1.70829232782226e-11	88	0	0	16	5310
WP619	Type II interferon signaling (IFNG)	1.00000000001731	1.73127763571861e-11	37	0	0	16	5310
WP3529	Zinc homeostasis	1.00000000001731	1.73127763571861e-11	37	0	0	16	5310
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1.00000000001731	1.73127763571861e-11	37	0	0	16	5310
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	1.00000000001731	1.73127763571861e-11	37	0	0	16	5310
WP1471	Target Of Rapamycin (TOR) Signaling	1.00000000001731	1.73127763571861e-11	37	0	0	16	5310
WP536	Calcium Regulation in the Cardiac Cell	1.00000000001881	1.88090543755798e-11	151	0	0	16	5310
WP3286	Copper homeostasis	1.00000000002154	2.15400488199459e-11	54	0	0	16	5310
WP623	Oxidative phosphorylation	1.00000000002154	2.15400488199459e-11	54	0	0	16	5310
WP673	ErbB Signaling Pathway	1.00000000002154	2.15400488199459e-11	54	0	0	16	5310
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1.00000000002154	2.15400488199459e-11	54	0	0	16	5310
WP2513	Nanoparticle triggered regulated necrosis	1.00000000002447	2.44680784868553e-11	11	0	0	16	5310
WP2854	Gene regulatory network modelling somitogenesis	1.00000000002447	2.44680784868553e-11	11	0	0	16	5310
WP80	Nucleotide GPCRs	1.00000000002447	2.44680784868553e-11	11	0	0	16	5310
WP3630	NAD metabolism, sirtuins and aging	1.00000000002447	2.44680784868553e-11	11	0	0	16	5310
WP1455	Serotonin Transporter Activity	1.00000000002447	2.44680784868553e-11	11	0	0	16	5310
